ITCMDBv1
Clinical TrialID 8528

Efficacy of Riboflavin-Enhanced Hyaluronic Acid Eye Drops in Treating Dry Eye Disease

NCT06122428

Dry Eye Disease

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final clinical_trial record.

Clinical Trial Id
8528
Evidence Id
8528
Core Evidence Id
8528
Source Clinical Trial Id
8527
Herb2 Clinical Trial Id
HBCT008527
Nct Id
NCT06122428
Title
Efficacy of Riboflavin-Enhanced Hyaluronic Acid Eye Drops in Treating Dry Eye Disease
Status
Completed
Phase
Study Result
No
Study Condition
Dry Eye Disease
Study Type
Observational
Study Design
Observational Model: |Time Perspective: p
Intervention
DRUG: modified hyaluronic acid 0.1% covalently linked to Riboflavin|DRUG: hyaluronic acid 0.1%
Intervention Allocation
Intervention Model
Intervention Mask
Intervention Purpose
Gender
All
Age
Adult, Older_Adult
Enrollment
16
Outcome Measure
Evaluate the efficacy and safety of a new 0.1% sodium hyaluronate-riboflavin-conjugated (HAr®) artificial tear in treating ocular discomfort and improving tear film stability in patients with dry eye disease., Ocular discomfort reduction mesured by OSDI test., From enrollment to the end of treatment at 8 weeks
Sponsor Collaborator
University of Naples
Funded By
OTHER
Location
University of Naples Federico II, NAples, 80131, Italy
Other Id
CIT_001
Start Date
2022-02-08
Primary Completion Date
2022-07-22
Completion Date
2022-10-10
First Posted
2023-11-08
Results First Posted
Last Update Posted
2023-11-08
Study Document
Study Url
https://clinicaltrials.gov/study/NCT06122428
Title Cn
Title En
Efficacy of Riboflavin-Enhanced Hyaluronic Acid Eye Drops in Treating Dry Eye Disease
Bilingual Status
semi_complete